37 related articles for article (PubMed ID: 15803927)
1. Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.
Akthar M; Nair N; Carter LM; Vital EM; Sutton E; McHugh N; ; ; Bruce IN; Reynolds JA
Arthritis Res Ther; 2023 Jun; 25(1):111. PubMed ID: 37391799
[TBL] [Abstract][Full Text] [Related]
2. Adhesion Molecule Targeted Therapy for Non-Infectious Uveitis.
Chen YH; Lightman S; Eskandarpour M; Calder VL
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008929
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of immunosuppression agents.
Elezaby A; Dexheimer R; Sallam K
Front Cardiovasc Med; 2022; 9():981838. PubMed ID: 36211586
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil.
Blaheta RA; Leckel K; Wittig B; Zenker D; Oppermann E; Harder S; Scholz M; Weber S; Schuldes H; Encke A; Markus BH
Transpl Immunol; 1998 Dec; 6(4):251-9. PubMed ID: 10342739
[TBL] [Abstract][Full Text] [Related]
5. The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells.
Leckel K; Beecken WD; Jonas D; Oppermann E; Coman MC; Beck KF; Cinatl J; Hailer NP; Auth MK; Bechstein WO; Shipkova M; Blaheta RA
Clin Exp Immunol; 2003 Nov; 134(2):238-45. PubMed ID: 14616783
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil.
Glomsda BA; Blaheta RA; Hailer NP
Spinal Cord; 2003 Nov; 41(11):610-9. PubMed ID: 14569262
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells.
Raab M; Daxecker H; Karimi A; Markovic S; Cichna M; Markl P; Müller MM
Clin Chim Acta; 2001 Aug; 310(1):89-98. PubMed ID: 11485760
[TBL] [Abstract][Full Text] [Related]
8. Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus.
Lewis MJ; D'Cruz D
Lupus; 2005; 14 Suppl 1():s17-26. PubMed ID: 15803927
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
Pisoni CN; Karim Y; Cuadrado MJ
Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
Dall'Era M
Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.
Mok CC
Scand J Rheumatol; 2007; 36(5):329-37. PubMed ID: 17963161
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
